Detailed Quote
Questions on this company?
Become a Member
Company Profile
{tplLang.businessdescription | toLang tLang}
{ profileData.description }
{tplLang.details | toLang tLang}
{tplLang.ceo | toLang tLang}
{profileData.profile.details.ceo}
{tplLang.employees | toLang tLang}
{profileData.profile.details.employees | numeraljs '0,0'}
{tplLang.issuetype | toLang tLang}
{profileData.profile.details.issuetype | asIssueType}
{tplLang.industryclassifications | toLang tLang}
{tplLang.sector | toLang tLang}
{profileData.profile.classification.sector}
{tplLang.industry | toLang tLang}
{profileData.profile.classification.industry}
{tplLang.toolname| toLang tLang}
There is no {tplLang.toolname| toLang tLang} currently available for
{data.symbolstring}.
Interactive Chart
Key Ratios
Earnings
Analyst Recommendations
5i Recent Questions
-
Celgene Corporation (CELG $108.24)
-
Bristol-Myers Squibb Company (BMY $46.69)
- $46.69 P/E (TTM): 17.67X Cap: $95.01B
- View BMY Profile
- View Questions on BMY
Q: Good morning team, with my celg shares gone, replaced with bmy and bmy.rt , my question is what to do with the bmy rights. Sell , hold or what will they may be worth in the future? Any thoughts?
Thanks, Michael
Thanks, Michael
-
Amgen Inc. (AMGN $295.87)
- $295.87 P/E (TTM): 26.87X Cap: $159.09B
- View AMGN Profile
- View Questions on AMGN
-
Biogen Inc. (BIIB $122.68)
- $122.68 P/E (TTM): 12.35X Cap: $17.97B
- View BIIB Profile
- View Questions on BIIB
-
Celgene Corporation (CELG $108.24)
Q: Which biopharma company is the “Best of Breed” to hold for at least 10 years. I am focused on total return over the holding period rather than dividend yield. Also please provide your views on Biogen, Amgen and Celgene. Thanks,
-
Amgen Inc. (AMGN $295.87)
- $295.87 P/E (TTM): 26.87X Cap: $159.09B
- View AMGN Profile
- View Questions on AMGN
-
Celgene Corporation (CELG $108.24)
-
Merck & Company Inc. (MRK $79.31)
- $79.31 P/E (TTM): 11.65X Cap: $199.14B
- View MRK Profile
- View Questions on MRK
-
Pfizer Inc. (PFE $24.26)
- $24.26 P/E (TTM): 17.73X Cap: $137.92B
- View PFE Profile
- View Questions on PFE
Q: Based on my portfolio review, I need to increase my pharmaceutical weighing. Although you do not follow US companies closely, could you give me your best recommendations for 3 US pharmaceutical Companies. My only holding at the moment is Pfizer. Could you give me your opinion on this company please?
Insiders
Share Information
SEC Filings
News and Media